Kepos Capital LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kepos Capital LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$762,000
-5.1%
68,3680.0%0.08%
+28.3%
Q1 2019$803,000
-12.0%
68,3680.0%0.06%
-14.3%
Q4 2018$913,000
-4.8%
68,3680.0%0.07%
+42.9%
Q3 2018$959,000
-23.7%
68,368
-14.5%
0.05%
-23.4%
Q2 2018$1,257,000
-4.4%
79,9370.0%0.06%
-16.9%
Q1 2018$1,315,00079,9370.08%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,372,001$98,287,0004.68%
TANAKA CAPITAL MANAGEMENT INC 79,574$934,0002.82%
Consonance Capital Management LP 3,747,453$43,995,0002.78%
S&T BANK/PA 613,740$7,205,0001.62%
AJ WEALTH STRATEGIES, LLC 595,834$6,995,0001.16%
Capital Impact Advisors, LLC 193,694$2,522,0001.12%
TEALWOOD ASSET MANAGEMENT INC 154,615$1,815,0000.77%
AMI ASSET MANAGEMENT CORP 722,932$8,487,0000.63%
Birchview Capital, LP 50,000$587,0000.37%
FEDERATED HERMES, INC. 11,176,281$131,210,0000.32%
View complete list of CORCEPT THERAPEUTICS INC shareholders